期刊文献+

益气养阴方对Graves病合并白细胞减少小鼠IL-13表达影响的实验研究

Experimental Study in Effect of Yiqiyangyin Decoction on IL-13of GD Combining With Leukopenia Mice
下载PDF
导出
摘要 目的观察Graves病(GD)小鼠外周血白细胞计数和小鼠细胞因子IL-13表达及益气养阴方对其的影响。方法基因枪造模建立GD小鼠模型,应用中药益气养阴方治疗后,观察小鼠外周血白细胞计数和小鼠细胞因子IL-13表达的变化。结果治疗30天后,在外周血白细胞计数方面,中药益气养阴方高剂量组明显高于中药益气养阴方低剂量组、中剂量组(P<0.01);在降低甲状腺激素水平方面,中药益气养阴方高、中剂量组明显优于中药益气养阴方低剂量组;在小鼠细胞因子IL-13表达方面,西药他巴唑组小鼠细胞因子IL-13表达显升高,与正常对照组和模型组比较有显著差异性(P<0.01)。中药治疗组的IL-13mRNA表达与正对照组比较没有显著性差异,P>0.05。经中药益气养阴方治疗,小鼠IL-13mRNA的表达下调,即中药高剂量组表达最低,依次增高。结论益气养阴方对Graves病合并白细胞减少有较好的治疗作用,其机理可能在于其能较好地调节Graves病小鼠细胞因子IL-13水平,有促进免疫细胞成熟、活化、增殖和免疫调节的作用。 Objective To observe the effect of Yiqiyangyin decoction on the peripheral white blood cell count and IL-13 expression of GD Mice To discuss the mechanism of yiqiyangyin decoction to merger leukopenia. Methods To establish the model of GD mice by Gene gun.After the therapy of Yiqiyangyin decoction,we observed the peripheral white blood cell count and IL-13 expression alteration of GD Mice.Results After the treatment in 30 days,the peripheral white blood cell count in high-dose group of Yiqiyangyin decoction was significantly higher than low-dose group and middle-dose group(P〈 0. 01). High-dose group and middle-dose group of Yiqiyangyin decoction was significantly superior to low-dose group in reducing thyroid hormones,. The tapazole group decreased obviously,which was significant difference with normal group in IL-13 expression(P〈 0. 01). There was no significant difference in IL-13 mRNA expression between chinese medicine treatment group and normal group(P〉 0. 05). After the treatment of Yiqiyangyin decoction,the IL-13 mRNA expression down regulated,which mean High-dose group express the lowest,with gradually increasing. Conclusions Yiqiyangyin decoction has a better therapeutic effect to Graves disease combining with leukopenia. Its mechanism may be related with better regulating IL-13 expression.Yiqiyangyin decoction can promote the maturation,activation,proliferation,and immunodulatory of immune cell.
机构地区 湖北省中医院
出处 《光明中医》 2014年第8期1615-1618,共4页 GUANGMING JOURNAL OF CHINESE MEDICINE
基金 湖北省科技计划自然科学基金一般项目(No.2009CDB284)
关键词 GRAVES病 白细胞减少 益气养阴 IL-13 实验研究 Graves disease Leukopenia Yiqiyangyin IL-13 Experimental study
  • 相关文献

参考文献10

  • 1Andres E, Maloisel F. Idiosyncratic drug-induced agranulocytosis [ J]. Rev Med Interne,2006,27 (3) :209-14. 被引量:1
  • 2Ibanez L, VidalX, Ballarin E, et al. Populatiorr based drug induced agranulocytosis [ J ]. Arch Intern Med, 2005,165 ( 8 ) : 869 -874. 被引量:1
  • 3徐叔云,卞如濂,陈修.药理实验方法学[M].3版.北京:人民卫生出版社,1995:936. 被引量:8
  • 4余毅恺..共刺激分子CD80分子上调Graves病免疫应答的临床和实验研究[D].华中科技大学,2008:
  • 5Saitoh O, Mizutori Y, Takamura N, et al. Adenovirus-mediated gene delivery of interleukin-lO, but not transforming growth factor beta,ameliorates the induction of Graves' hyperthyroidism in BALB/c mice[ J]. Clin Exp Immunol,2005, 141:405-11. 被引量:1
  • 6Devfies J E, Zurawski G. Immunoregalatory properties of IL-13 : its potential Role in Atopic Disease [ J ]. Int Arch Allergy Immune, 1995,106 : 17. 被引量:1
  • 7何晓璐,石小玉.白介素13受体α2的研究进展[J].实用临床医学(江西),2009,10(1):136-138. 被引量:2
  • 8龚非力主编..医学免疫学 第2版[M].北京:科学出版社,2004:496.
  • 9Peng Q, Matsuda T, Hirst SJ. Signaling pathways regulating in- terleukin-13-stimulated chemokine release from airway smooth muscle[ J]. Am J Respir Crit Care Med,2004,169(5) : 596-603. 被引量:1
  • 10Faffe DS, Flynt L, Mellema M,et al. Causes eotaxln-1 release from airway smooth muscle: synergy with IL-4 and IL-13 [ J ]. J Allergy Clin Immuno1,2005,115 ( 3 ) :514-520. 被引量:1

二级参考文献21

  • 1Shirwan H. Chronic Allograft Rejection. Do the Th2 Cells Preferentially Induced by Indirect Alloantigen Recognition Play a Dominant Role? [J].Transplantation, 1999,68 : 715- 726. 被引量:1
  • 2Kawakami K, Kawakami M,Puri R K. IL-13 Receptor-target Cytotoxin Cancer Therapy Leads to Complete Eradication of Tumors with the Aid of Phagocytic Cells in Nude Mice Model of Human Cancer[J]. Immunl,2002,169:7119-7126. 被引量:1
  • 3Devries J E, Zurawski G. Immunoregalatory Properties of IL- 13:its Potential Role in Atopic Disease[J]. Int Arch Allergy Immune, 1995,106 : 17. 被引量:1
  • 4Bai A, Eidelman D H, Hogg J C, et al. Proposed Nomenclature for Quantifying Subdivisions of the Bronchial Wall[J]. Appl Physiol, 1994,77(2) : 1011-1014. 被引量:1
  • 5Donaldson D D, Whitters M J, Fitz L J, et al. The Murine IL- 13receptor Alpha 2 : Molecular Cloning, Characterization, and Comparison with Murine IL-13 Receptor Alphal[J]. Immunol, 1998,161 : 2317-2324. 被引量:1
  • 6Michael O D, Yasuhiro T, Bradley A W,et al. Level of Expression of IL-13Ra2 Impacts Receptor Distribution and IL-13 Signaling[J]. Immunol. 2006,176 : 7495-7501. 被引量:1
  • 7Daines M O, Hershey G K. A Novel Mechanism by which Interferon-gamma can Regulate Interleukin(IL)-13 Responses. Evidence for lntracellular Stores of IL-13 Receptor Alpha 2 and their Rapid Mobilization by Interferon-gamma[J]. Biol Cherm, 2002,22,227 (12) : 10387-1093. 被引量:1
  • 8David M,Ford D,Bertoglio J,et al. Induction of the IL-13 receptor-chain by IL-4 and IL-13 in Human Keratinocytes: Involvement of STAT6, ERK and p38 MAPK Pathways[J]. Oncogene 2001,20 : 6660-6668. 被引量:1
  • 9Mentink K,Cheever A W,Thompson R W,et al. IL-13 Receptor a2 Down-modulates Granulomatous Inflammation and Prolongs Host Survival in Schistosomiasis[J]. Proc Natl Acad Sci USA, 2004,101 : 586-590. 被引量:1
  • 10Yasunaga S,Yuyama N,Arima K,et al. The Negative-feedback Regulation of the IL-13 Signal by the IL-13 Receptor 2 Chain in Bronchial Epithelial Cells[J]. Cytokine, 2003,24 : 293-303. 被引量:1

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部